Alberto Costantini

403 total citations
31 papers, 263 citations indexed

About

Alberto Costantini is a scholar working on Family Practice, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Alberto Costantini has authored 31 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Family Practice, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Economics and Econometrics. Recurrent topics in Alberto Costantini's work include Medication Adherence and Compliance (8 papers), Pharmaceutical studies and practices (5 papers) and Economic and Financial Impacts of Cancer (3 papers). Alberto Costantini is often cited by papers focused on Medication Adherence and Compliance (8 papers), Pharmaceutical studies and practices (5 papers) and Economic and Financial Impacts of Cancer (3 papers). Alberto Costantini collaborates with scholars based in Italy, Netherlands and South Africa. Alberto Costantini's co-authors include Paola Sorice, Giustino Parruti, Ennio Polilli, Valerio Scartoni, Oreste Livi, Marcella Rinaldi, Luca Costantino, Giuliana Biagi, Irene Giorgi and Antonio Di Stefano and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Patient Education and Counseling.

In The Last Decade

Alberto Costantini

30 papers receiving 259 citations

Peers

Alberto Costantini
Anat Fisher Canada
Cornelia Mrazek Austria
Rani Khatib United Kingdom
Long Meng China
Evan Davies United States
Takeo Yasu Japan
Jill Bates United States
Jacob Sevastos Australia
Bipin Vadher United Kingdom
Giuseppe Traversa Italy
Anat Fisher Canada
Alberto Costantini
Citations per year, relative to Alberto Costantini Alberto Costantini (= 1×) peers Anat Fisher

Countries citing papers authored by Alberto Costantini

Since Specialization
Citations

This map shows the geographic impact of Alberto Costantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Costantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Costantini more than expected).

Fields of papers citing papers by Alberto Costantini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Costantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Costantini. The network helps show where Alberto Costantini may publish in the future.

Co-authorship network of co-authors of Alberto Costantini

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Costantini. A scholar is included among the top collaborators of Alberto Costantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Costantini. Alberto Costantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciulla, Michele, Lisa Marinelli, Giuseppe Di Biase, et al.. (2023). Healthcare Systems across Europe and the US: The Managed Entry Agreements Experience. Healthcare. 11(3). 447–447. 25 indexed citations
2.
Mucherino, Sara, Valentina Orlando, Piera Polidori, et al.. (2022). Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm). International Journal of Clinical Pharmacy. 44(4). 1037–1045. 3 indexed citations
3.
Costantini, Alberto, et al.. (2022). Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs. European Journal of Hospital Pharmacy. 30(6). 328–332. 5 indexed citations
4.
Costantini, Alberto, et al.. (2022). A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions. Journal of Oncology Pharmacy Practice. 29(8). 1806–1815. 4 indexed citations
5.
6.
7.
Costantini, Alberto, et al.. (2021). Adherence and persistence in the use of statins and ezetimibe over 8 years in a real-life study. Current Medical Research and Opinion. 37(12). 2061–2066. 7 indexed citations
8.
Costantini, Alberto, et al.. (2021). The impact of COVID-19 on chronic therapies: the Pescara (ASL) local health authority experience in Italy. Current Medical Research and Opinion. 38(2). 311–316. 6 indexed citations
9.
Costantini, Alberto, et al.. (2021). Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life. Patient Education and Counseling. 104(8). 2012–2017. 3 indexed citations
10.
Potere, Nicola, Marcello Di Nisio, Giulia Rizzo, et al.. (2020). Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation. International Journal of Infectious Diseases. 100. 421–424. 25 indexed citations
11.
Costantini, Alberto, et al.. (2020). Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials. European Journal of Clinical Pharmacology. 76(6). 843–850. 4 indexed citations
12.
Rocchi, Marco, et al.. (2020). Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting. Journal of Oncology Pharmacy Practice. 28(1). 24–30. 4 indexed citations
13.
Costantini, Alberto, et al.. (2019). La Real World Data e la Farmacoutilizzazione: strumenti per il farmacista ospedaliero. 33(2). 77–85. 1 indexed citations
14.
Costantini, Alberto, et al.. (2019). Dosage adjustments in pivotal clinical trials with oral targeted therapies in solid tumors conducted in Europe. European Journal of Clinical Pharmacology. 75(5). 697–706. 3 indexed citations
15.
Frattari, Antonella, Vincenzo Savini, Ennio Polilli, et al.. (2019). Control of Gram-negative multi-drug resistant microorganisms in an Italian ICU: Rapid decline as a result of a multifaceted intervention, including conservative use of antibiotics. International Journal of Infectious Diseases. 84. 153–162. 18 indexed citations
16.
Ammazzalorso, Alessandra, et al.. (2018). Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period. Drugs & Therapy Perspectives. 34(6). 263–268. 1 indexed citations
17.
Parruti, Giustino, Ennio Polilli, Valeria Cento, et al.. (2016). Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district. ClinicoEconomics and Outcomes Research. Volume 8. 467–473. 11 indexed citations
18.
19.
Sorice, Paola, et al.. (2014). Medication adherence and persistence in the treatment of rheumatoid arthritis with adalimumab and etanercept. Six years of analysis. Journal of Medical Economics. 17(5). 320–325. 7 indexed citations
20.
Sorice, Paola, et al.. (2013). Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice. PLoS ONE. 8(2). e56813–e56813. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anat Fisher Breakdown of academic impact, for papers by Cornelia Mrazek Breakdown of academic impact, for papers by Rani Khatib Breakdown of academic impact, for papers by Long Meng Breakdown of academic impact, for papers by Evan Davies Breakdown of academic impact, for papers by Takeo Yasu Breakdown of academic impact, for papers by Jill Bates Breakdown of academic impact, for papers by Jacob Sevastos Breakdown of academic impact, for papers by Bipin Vadher Breakdown of academic impact, for papers by Giuseppe Traversa
Rankless by CCL
2026